opioid antagonist. Exhibits partial agonist in vitro
activity at δ
receptors at high concentrations.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Sold with the permission of AstraZeneca UK Ltd.
Opioid agonist activity of ICI 174864 and its carboxypeptidase degradation product, LY281217.
Cohen et al.
ICI-174,864: a highly selective antagonist for the opioid δ receptor.
Cotton et al.
Studies in vivo with ICI-174,864 and [D-Pen2,D-Pen5]-enkephalin.
Cowan et al.
Studies in vitro with ICI-174,864 [D-Pen2,D-Pen5]-enkephalin (DPDPE) and [D-Ala2,NMePhe4,Gly-ol]-enkephalin (DAGO).
Hirning et al.
The citations listed below are publications that use Tocris products. Selected citations for ICI 174,864 include:
Showing Results 1 - 3 of 3